Figure 1.
Figure 1. Analysis of apoptosis and DR5 in HIV-1–infected patients and uninfected controls. (A) Flow cytometric analysis of annexin V+ and DR5+ CD4+ T cells from 16 uninfected control donors (HIV-) and 22 HIV-1–infected patients (HIV+). P values were calculated using 2-tailed Student t test. (B) Linear regression analysis of DR5-mediated CD4+ T-cell apoptosis (DR5+annexin V+) compared with all apoptotic CD4+ T cells (annexin V+) performed in the same cohort. (C) PBMCs from 5 HIV-1–infected patients were cultured for 48 hours with (+) or without (-) anti-DR5 blocking antibody. CD3+ CD4+ T cells were analyzed for annexin V by FACS.

Analysis of apoptosis and DR5 in HIV-1–infected patients and uninfected controls. (A) Flow cytometric analysis of annexin V+ and DR5+ CD4+ T cells from 16 uninfected control donors (HIV-) and 22 HIV-1–infected patients (HIV+). P values were calculated using 2-tailed Student t test. (B) Linear regression analysis of DR5-mediated CD4+ T-cell apoptosis (DR5+annexin V+) compared with all apoptotic CD4+ T cells (annexin V+) performed in the same cohort. (C) PBMCs from 5 HIV-1–infected patients were cultured for 48 hours with (+) or without (-) anti-DR5 blocking antibody. CD3+ CD4+ T cells were analyzed for annexin V by FACS.

Close Modal

or Create an Account

Close Modal
Close Modal